Objective:To analyze the early outcomes of self-made false lumen embolization device for occlusion the false lumen in chronic Stanford type B aortic dissection.Methods:A retrospective study analyzed 10 patients, there were 9 males and 1 female, with an average age of (52±10) years, aged from 39-69 years. Those 10 patients were diagnosed with chronic Stanford type B aortic dissection between June 2020 and July 2023, which presented with persistent false lumen backflow in the thoracic aortic segment, and persistent dilation or rupture of dissected aneurysms in our center. False lumen occlusion was performed using self-made false lumen embolization device. Primary endpoints index were technical success rate and clinical success rate. Secondary endpoints observation index were 30-day mortality and morbidity.Results:Over a mean 6-month follow-up (range 0-32 months) in 10 patients, the technical success rate was 90%. One patient occurred minor false lumen backflow in the intraoperative angiography and it exceeds the embolization device, but it was disappeared through conservative treatment during follow up period. The clinical success rate was 90%, 9 patients attained completely thrombosed at the thoracic segment while another 1 patient was manifested as partially thrombosed in false lumen. There were no intraprocedural death cases and 1 patient occurred paraparesis during perioperative period.Conclusion:It was a safe, effective and easy to achieve in the treatment of chronic Stanford type B aortic dissection using self-made false lumen embolization device, especially it is suitable for patients with chronic Stanford type B aortic dissection required emergent handling in the setting of rupture.